Report Highlights
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Report Includes
- 47 data tables and 45 additional tables
- An analysis of the global markets for ophthalmic devices, diagnostics and surgical equipment
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and revenue forecasts and projections of compound annual growth rates (CAGRs) through 2028
- An estimate of the market size, with corresponding market share analyses by product, end user, disorder type and region.
- Discussions of the market opportunities for ophthalmic diagnostics, its clinical applications, clinical trials, structure of the industry, regulatory scenario and device technology
- Information pertaining to the major market dynamics, challenges and deterrents, emerging technologies and future prospects.
- Discussion of ESG, including consumer attitudes, its impact on company performance, and ESG practices of leading companies.
- Review of the key patents related to ophthalmic devices and surgical equipment
- Overview of the major vendors, along with an analysis of their market shares, revenues by market segment, recent M&A activity and other corporate developments, and the outlook for venture funding
- Profiles of the leading market players
Report Scope
This report aims to comprehensively study the global market size of ophthalmic devices, diagnostics and surgical equipment. Current and historical market revenues can be estimated based on the technology, by product, end user, disease, and region.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||||||
Forecast period considered | 2023-2028 | ||||||||||||
Base year market size | $30.6 billion | ||||||||||||
Market size forecast | $44.0 billion | ||||||||||||
Growth rate | CAGR of 6.3% from 2023 to 2028 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Product, End User, Disorder Type, and Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of World | ||||||||||||
Countries covered | United States, Canada, Mexico, Germany, UK, France, Switzerland, Russia, China, India, Japan, Singapore, and Philippines | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for ophthalmic devices, diagnostics and surgical equipment is estimated to grow from $23.4 billion in 2021 to reach $30.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2021-2026.
Report Includes
- 186 data tables and 12 additional tables
- An updated review of the global market for ophthalmic devices, diagnostics and surgical equipment
- Analyses of the global market trends, with data from 2018-2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Estimation of current market size and potential growth forecast for ophthalmic devices, diagnostics and surgical equipment market, and corresponding market share analysis by product type, end user, application and geographic region
- Discussion of market opportunities for ophthalmic diagnostics, clinical applications, industry structure, regulatory scenario, and penetration of technologies within the medical devices industry
- Highlights of key market dynamics, trends, opportunities, and factors influencing the demand within global ophthalmic market and its sub-segments
- In-depth analysis for each of the market segments based on the product type such as contact lens, ophthalmic surgical, and ophthalmic diagnostic devices at the regional and country level
- Coverage of country specific data and analysis for the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea and Australia within the regional segment
- Review of challenges and market deterrents that need to be addressed in the global market to achieve fiscal success
- Assessment of the key market players and their product portfolios, recent developments, and areas of application in ophthalmic devices, diagnostics and surgical equipment
- Descriptive company profiles of the market leading participants, including Alcon AG, Bausch + Lomb Inc., Carl Zeiss AG, CooperVision Inc., EssilorLuxottica, Hoya Corp., and Seiko Opticals
Report Highlights
The global market for ophthalmic devices, diagnostics, and surgical equipment was valued at nearly $16.9 billion in 2012, up from $16.2 billion in 2011. The market is expected to reach $20.2 billion in 2017, an increase of nearly $3.4 billion during the forecast period and a compound annual growth rate (CAGR) of 3.7% from 2012 to 2017.
Report Includes
- An overview of the global markets for ophthalmic devices, diagnostics, and surgery
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of products by product type and, where applicable, by disease type
- Examination of general areas identified with appropriate subsegments, including imaging equipment and nonimaging exam diagnostics, the contact lens market, the surgical market, and intraocular lenses, shunts and other drainage devices
- Discussion in terms of use, with a focus on specific diseases and conditions such as cataract treatments, glaucoma treatments, and refractive treatments; each segment provides detailed information of products, current market estimates, and market forecasts
- Comprehensive company profiles of major players in the industry.
Report Highlights
- The global market for ophthalmic devices, diagnostics, and surgical equipment was valued at $15.2 billion in 2009, up from $13.5 billion in 2007. The market is estimated to reach $19 billion in 2014, an increase of nearly $4 billion over the forecast period and a compound annual growth rate (CAGR) of 4.6% from 2009 to 2014.
- Contact lenses, including both functional and cosmetic lenses, account for 43% of the worldwide market. This segment was worth $6.6 billion in 2009 and is expected to increase to $7.7 billion in 2014, a compound annual growth rate (CAGR) of 3.3%.
- Surgical equipment generated a market worth $5.5 billion in 2009, accounting for 36% of the total market. By 2014, this sector will be valued at an estimated $7.3 billion, a compound annual growth rate (CAGR) of 5.9%.
Related Reports
Ophthalmic Devices: Technologies and Global Markets
The global market for ophthalmic devices is estimated to increase from $47.5 billion in 2022 to reach $64.2 billion by 2027, at a compound annual growth rate (CAGR) of 6.2% from 2022 through 2027.
Vision Care: Global Markets
The global market for vision care should grow from $63.1 billion in 2020 to $77.5 billion by 2025 at a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2020-2025.
Optical Coatings: Technologies and Global Markets
The global market for optical coatings is expected to reach $14.2 billion by 2021 from $9.5 billion in 2016, rising at a compound annual growth rate (CAGR) of 8.3% from 2016 through 2021.
Ophthalmic Therapeutic Drugs: Technologies and Global Markets
The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2019, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2019.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More